These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2984563)

  • 1. Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy.
    Holland FJ; Fishman L; Bailey JD; Fazekas AT
    N Engl J Med; 1985 Apr; 312(16):1023-8. PubMed ID: 2984563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-independent precocious puberty ("testotoxicosis"): influence of maturational status on response to ketoconazole.
    Holland FJ; Kirsch SE; Selby R
    J Clin Endocrinol Metab; 1987 Feb; 64(2):328-33. PubMed ID: 3539979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone release hormone (D-Tryp6-GnRH) in monthly injections. Its possible use in normal puberty.
    Marcondes JA; Abujamra AC; Minanni SL; Mendonca BB; Nery M; Lerario AC; Pereira MA; Abelin N; Wajchenberg BL
    Horm Metab Res; 1993 Feb; 25(2):105-9. PubMed ID: 8458605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of central precocious puberty with an LHRH analog. Effect on growth and bone maturation after 2 years of treatment].
    Brauner R; Rappaport R
    Arch Fr Pediatr; 1987 Apr; 44(4):271-6. PubMed ID: 3109347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ; Beardsworth DE; Loughlin JS; Crawford JD; Bode HH; Rivier J; Vale W; Kushner DC; Crigler JF; Crowley WF
    N Engl J Med; 1983 Nov; 309(21):1286-90. PubMed ID: 6415479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of familial male precocious puberty with spironolactone and testolactone.
    Laue L; Kenigsberg D; Pescovitz OH; Hench KD; Barnes KM; Loriaux DL; Cutler GB
    N Engl J Med; 1989 Feb; 320(8):496-502. PubMed ID: 2492636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole.
    Almeida MQ; Brito VN; Lins TS; Guerra-Junior G; de Castro M; Antonini SR; Arnhold IJ; Mendonca BB; Latronico AC
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):93-8. PubMed ID: 18088394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
    Lamberts SW; Uitterlinden P; de Jong FH
    Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of male-limited gonadotropin-independent precocious puberty.
    Bertelloni S; Baroncelli GI; Lala R; Cappa M; Matarazzo P; De Sanctis C; Saggese G
    Horm Res; 1997; 48(5):235-9. PubMed ID: 9362394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monitoring the treatment of precocious puberty with a GnRH-analog (buserelin): comparison of the GnRH-test with nocturnal pulsatility of LH, testosterone and 17-beta-estradiol].
    Radetti G; Pasquino B; Castellan C; Gentili L; Mengarda G
    Pediatr Med Chir; 1991; 13(5):471-4. PubMed ID: 1788106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report.
    Comite F; Cutler GB; Rivier J; Vale WW; Loriaux DL; Crowley WF
    N Engl J Med; 1981 Dec; 305(26):1546-50. PubMed ID: 6458765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on cases of precocious puberty].
    Nanbu A; Kumamoto Y; Takagi Y; Maruta H
    Hinyokika Kiyo; 1989 Oct; 35(10):1715-20. PubMed ID: 2532862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of central precocious puberty with an LHRH agonist (Buserelin): effect on growth and bone maturation after three years of treatment.
    Rappaport R; Fontoura M; Brauner R
    Horm Res; 1987; 28(2-4):149-54. PubMed ID: 2969858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J; Reynaud R; Czernichow P
    J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Puberty without gonadotropins. A unique mechanism of sexual development.
    Wierman ME; Beardsworth DE; Mansfield MJ; Badger TM; Crawford JD; Crigler JF; Bode HH; Loughlin JS; Kushner DC; Scully RE
    N Engl J Med; 1985 Jan; 312(2):65-72. PubMed ID: 3917301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
    Feuillan PP; Foster CM; Pescovitz OH; Hench KD; Shawker T; Dwyer A; Malley JD; Barnes K; Loriaux DL; Cutler GB
    N Engl J Med; 1986 Oct; 315(18):1115-9. PubMed ID: 3093862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precocious puberty associated with neurofibromatosis and optic gliomas. Treatment with luteinizing hormone releasing hormone analogue.
    Laue L; Comite F; Hench K; Loriaux DL; Cutler GB; Pescovitz OH
    Am J Dis Child; 1985 Nov; 139(11):1097-100. PubMed ID: 3933329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel testis-stimulating factor in familial male precocious puberty.
    Manasco PK; Girton ME; Diggs RL; Doppman JL; Feuillan PP; Barnes KM; Cutler GB; Loriaux DL; Albertson BD
    N Engl J Med; 1991 Jan; 324(4):227-31. PubMed ID: 1898671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal LH-RH analogue treatment of precocious puberty.
    Koehler B; Koehler M; Osuch-Jaczewska R
    Exp Clin Endocrinol; 1988 Mar; 92(3):252-6. PubMed ID: 3075552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of central precocious puberty using an intranasal LHRH analogue (buserelin).
    Stanhope R; Adams J; Brook CG
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):795-806. PubMed ID: 3926352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.